Class information for:
Level 1: RFVIIA//RECOMBINANT ACTIVATED FACTOR VII//RECOMBINANT FACTOR VIIA

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
6718 1377 29.7 82%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
618 13204 HAEMOPHILIA//HAEMOPHILIA A//VON WILLEBRAND DISEASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RFVIIA Author keyword 196 70% 12% 163
2 RECOMBINANT ACTIVATED FACTOR VII Author keyword 184 71% 11% 148
3 RECOMBINANT FACTOR VIIA Author keyword 146 59% 12% 162
4 NOVOSEVEN Author keyword 94 85% 4% 50
5 FACTOR VIIA Author keyword 42 32% 8% 106
6 RECOMBINANT FVIIA Author keyword 38 65% 3% 36
7 RECOMBINANT ACTIVATED FACTOR VII RFVIIA Author keyword 32 78% 2% 21
8 NOVOSEVEN R Author keyword 29 88% 1% 14
9 BYPASSING AGENTS Author keyword 24 60% 2% 26
10 RECOMBINANT ACTIVATED FVII Author keyword 21 85% 1% 11

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 RFVIIA 196 70% 12% 163 Search RFVIIA Search RFVIIA
2 RECOMBINANT ACTIVATED FACTOR VII 184 71% 11% 148 Search RECOMBINANT+ACTIVATED+FACTOR+VII Search RECOMBINANT+ACTIVATED+FACTOR+VII
3 RECOMBINANT FACTOR VIIA 146 59% 12% 162 Search RECOMBINANT+FACTOR+VIIA Search RECOMBINANT+FACTOR+VIIA
4 NOVOSEVEN 94 85% 4% 50 Search NOVOSEVEN Search NOVOSEVEN
5 FACTOR VIIA 42 32% 8% 106 Search FACTOR+VIIA Search FACTOR+VIIA
6 RECOMBINANT FVIIA 38 65% 3% 36 Search RECOMBINANT+FVIIA Search RECOMBINANT+FVIIA
7 RECOMBINANT ACTIVATED FACTOR VII RFVIIA 32 78% 2% 21 Search RECOMBINANT+ACTIVATED+FACTOR+VII+RFVIIA Search RECOMBINANT+ACTIVATED+FACTOR+VII+RFVIIA
8 NOVOSEVEN R 29 88% 1% 14 Search NOVOSEVEN+R Search NOVOSEVEN+R
9 BYPASSING AGENTS 24 60% 2% 26 Search BYPASSING+AGENTS Search BYPASSING+AGENTS
10 RECOMBINANT ACTIVATED FVII 21 85% 1% 11 Search RECOMBINANT+ACTIVATED+FVII Search RECOMBINANT+ACTIVATED+FVII

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 RFVIIA 335 81% 15% 204
2 NOVOSEVENR 205 80% 9% 129
3 ACTIVATED FACTOR VII 198 34% 35% 479
4 DOSE FACTOR VIIA 116 73% 7% 90
5 RECOMBINANT FACTOR VIIA 79 23% 22% 302
6 NOVOSEVEN 60 75% 3% 43
7 FACTOR VLLA 58 92% 2% 23
8 BLEEDING EPISODES 44 58% 4% 51
9 FVIIA 40 76% 2% 28
10 CELL BASED MODEL 37 55% 3% 46

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications 2011 90 84 76%
Recombinant activated factor VII in cardiac surgery: A systematic review 2007 73 64 77%
Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors 2004 176 56 79%
The use of recombinant factor VIIa in the treatment of bleeding disorders 2004 160 65 85%
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review 2005 183 47 83%
Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies 2015 1 14 79%
Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors 2008 44 10 90%
Efficacy and safety of recombinant activated factor VII in major surgical procedures 2008 41 58 86%
Mechanisms and monitoring of bypassing agent therapy 2012 22 53 55%
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia 2007 43 40 85%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CENT VIRGINIA COAGULAT DISORDERS 8 62% 0.6% 8
2 COAGULAT ADVANCEMENT 4 75% 0.2% 3
3 ISRAELI HEMOPHILIA 3 50% 0.4% 5
4 NOVOSEVEN 3 100% 0.2% 3
5 SO ALBERTA HEMOPHILIA CLIN 3 45% 0.4% 5
6 TRAITEMENT HEMOPHILES 3 31% 0.6% 8
7 BIOPHARMACEUT UNIT 3 17% 1.1% 15
8 HAEMOPHILIA THROMBOSIS 3 12% 1.5% 21
9 UNITE HEMOSTASE CLIN 2 23% 0.7% 9
10 BIOPHARM MFG DEV 2 67% 0.1% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000191962 THROMBIN GENERATION//SYN SE BV//PHYS BIOCHEM BLOOD
2 0.0000162974 PROTHROMBIN COMPLEX CONCENTRATE//PROTHROMBIN COMPLEX CONCENTRATES//ANTICOAGULATION REVERSAL
3 0.0000154710 FACTOR VIII//FACTOR VIII INHIBITOR//ACQUIRED HEMOPHILIA
4 0.0000136242 MASSIVE TRANSFUSION//THROMBOELASTOMETRY//THROMBOELASTOGRAPHY
5 0.0000129767 HAEMOPHILIA//VAN CREVELDKLIN//HEMOPHILIA
6 0.0000107092 FACTOR VII DEFICIENCY//FACTOR X DEFICIENCY//FACTOR VII
7 0.0000083481 SECT HEPATOBILIARY SURG LIVER TRANSPLANTAT//AMINO ACIDS THERAPEUTIC USE//LIVER DISEASES COMPLICATIONS
8 0.0000073950 PSEUDO TUMOURS//HAEMOPHILIC PSEUDOTUMOUR//PSEUDOTUMOUR
9 0.0000062048 TISSUE FACTOR//TISSUE FACTOR PATHWAY INHIBITOR//TFPI
10 0.0000061775 APROTININ//TRANEXAMIC ACID//EPSILON AMINOCAPROIC ACID